Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insight Molecular Diagnostics (IMDX) Depreciation & Amortization (CF) (2020 - 2025)

Historic Depreciation & Amortization (CF) for Insight Molecular Diagnostics (IMDX) over the last 6 years, with Q3 2025 value amounting to $584000.0.

  • Insight Molecular Diagnostics' Depreciation & Amortization (CF) rose 8364.78% to $584000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 million, marking a year-over-year increase of 7748.99%. This contributed to the annual value of $1.5 million for FY2024, which is 625.0% down from last year.
  • Latest data reveals that Insight Molecular Diagnostics reported Depreciation & Amortization (CF) of $584000.0 as of Q3 2025, which was up 8364.78% from $559000.0 recorded in Q2 2025.
  • In the past 5 years, Insight Molecular Diagnostics' Depreciation & Amortization (CF) ranged from a high of $584000.0 in Q3 2025 and a low of $121000.0 during Q1 2021
  • Over the past 5 years, Insight Molecular Diagnostics' median Depreciation & Amortization (CF) value was $384000.0 (recorded in 2022), while the average stood at $367263.2.
  • In the last 5 years, Insight Molecular Diagnostics' Depreciation & Amortization (CF) surged by 26956.52% in 2021 and then tumbled by 3044.44% in 2024.
  • Quarter analysis of 5 years shows Insight Molecular Diagnostics' Depreciation & Amortization (CF) stood at $218000.0 in 2021, then soared by 83.49% to $400000.0 in 2022, then dropped by 25.0% to $300000.0 in 2023, then surged by 88.33% to $565000.0 in 2024, then grew by 3.36% to $584000.0 in 2025.
  • Its Depreciation & Amortization (CF) was $584000.0 in Q3 2025, compared to $559000.0 in Q2 2025 and $484000.0 in Q1 2025.